Advertisement

Topics

DNage Company Presentation Company Profile

22:20 EDT 22nd September 2018 | BioPortfolio

DNage is a biopharmaceutical company developing products for medical and health problems associated with ageing. The company was spun out from the Erasmus Medical Center in Rotterdam in 2004 and financed by dedicated life science investors.The Company has several products under development all based on technology and knowledge developed at the Erasmus Medical Center.

Location

DR Molenwaterplein 50
Rotterdam
3015 GE`
Netherlands

Contact

Phone: 31 715 276 354
Fax: 31 653 912 661
Email: r.strijker@dnage.nl


News Articles [500 Associated News Articles listed on BioPortfolio]

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2017

Change in Presentation Currency Effective December 31, 2017, the Company changed its presentation currency from the United Statesdollar to the euro. The Company Read more...

Download presentation: Sharing space

At the last Healthcare World Asia in 2013, Jon Roberts gave the following presentation entitled: Sharing space. Download this presentation today! Some points discussed during this presentation includ...

Navamedic ASA: Invitation to presentation of first quarter 2018

Navamedic ASA invites you to a presentation of the first quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Wednesday 30 May. The presentation...

Navamedic ASA: Invitation to presentation of second quarter 2018

Navamedic ASA invites you to a presentation of the second quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Friday 24 August. The presentati...

Civitas Solutions, Inc. Announces Time Change for Presentation at Barclays Global Healthcare Conference

Civitas Solutions, Inc. (NYSE:CIVI) today announced a time change for its upcoming presentation at the Barclays Global Healthcare Conference. The presentation details are as follo...

Photocure ASA: Presentation of the second quarter and first half year 2018 results

Photocure will present its second quarter and first half year report on Wednesday 8 August 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and repres...

Download Presentation: Exploring strategies for effective use of IT in Connexion

James Woo, CIO of The Farrer Park Company gave the following presentation at the last Healthcare World Asia 2013 entitled: Exploring strategies for effective use of IT in Connexion. Some of the major ...

PCI Biotech: Invitation to first quarter 2018 presentation

Oslo,Norway, 2 May 2018 - PCI Biotech invites to a presentation of the company's first quarter 2018 report on Tuesday 8 May 2018 at Oslo Cancer Cluster Innovation Park. Time: Tues...

PubMed Articles [539 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

Spontaneous Version of Fetal Presentation in Twin Pregnancies During Third Trimester: Longitudinal Assessment.

Little is known about longitudinal changes of the first twin presentation in twin gestations. This is a retrospective cohort study including 411 women who were admitted consecutively and delivered liv...

A Man (or a Woman) is Known by the Company He/She Keeps.

Antigen presentation unfolded: identifying convergence points between the UPR and antigen presentation pathways.

The unfolded protein response (UPR) is an adaptive response meant to restore endoplasmic reticulum homeostasis in conditions of ER stress that subvert the folding capacity of the cell. Over the past f...

A small Glossopharyngeal schwannoma presenting with intractable vomiting: case presentation and literature review.

Glossopharyngeal schwannomas are rare tumors. Clinical and radiological presentation closely resembles those of vestibular schwannomas. Their clinical presentation varies from vestibulocochlear dysfun...

Clinical Trials [475 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Effects of Bedside Compared to Outside the Room Case Presentation

Patient case presentations during ward rounds can take place at the bedside or outside the room. The best approach to patient case presentation is yet unclear. Thus, the overall aim of thi...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Presentation of Lumbar Disc and Reduction of Symptoms

The trial aims to assess the hypothesis that presentation of the disc material to the patient following a lumbar microdiscectomy would positively influence the improvement in their leg and...

Presenting Summary Information From Cochrane Systematic Reviews

The objective of the investigators study is to evaluate the efficacy of infographics in presenting information, in terms of understanding and remembering research results, compared to stan...

Companies [1490 Associated Companies listed on BioPortfolio]

DNage Company Presentation

DNage is a biopharmaceutical company developing products for medical and health problems associated with ageing. The company was spun out from the Erasmus Medical Center in Rotterdam in 2004 and finan...

Nanodisc, Inc.

Nanodisc, Inc. owns an exclusive, world-wide commercial license to all applications of Nanodiscs™ – nano scale, discoidal structures composed of specially engineered proteins and phosphol...

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

Projection Presentation Technology

Projection was founded in the Washington, DC area in 1971 by David Campbell. In the last three decades, Mr. Campbell has successfully expanded his company into 19 cities across the country and current...

More Information about "DNage Company Presentation" on BioPortfolio

We have published hundreds of DNage Company Presentation news stories on BioPortfolio along with dozens of DNage Company Presentation Clinical Trials and PubMed Articles about DNage Company Presentation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DNage Company Presentation Companies in our database. You can also find out about relevant DNage Company Presentation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record